Mitotic Intragenic Recombination: A Mechanism of Survival for Several Congenital Disorders of Glycosylation
- 1 February 2016
- journal article
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 98 (2) , 339-346
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Frequent somatic reversion of KRT1 mutations in ichthyosis with confettiJournal of Clinical Investigation, 2015
- Understanding Human Glycosylation Disorders: Biochemistry Leads the ChargeJournal of Biological Chemistry, 2013
- Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombinationJournal of Clinical Investigation, 2012
- Depletion of Werner helicase results in mitotic hyperrecombination and pleiotropic homologous and nonhomologous recombination phenotypesMechanisms of Ageing and Development, 2010
- Glycosylation diseases: Quo vadis?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Gene conversion: mechanisms, evolution and human diseaseNature Reviews Genetics, 2007
- Congenital Disorders of N-Glycosylation Including Diseases Associated With O- as Well as N-Glycosylation DefectsPediatric Research, 2006
- In vivo reversion to normal of inherited mutations in humansJournal of Medical Genetics, 2003
- Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia)Human Mutation, 2000
- A Novel Disorder Caused by Defective Biosynthesis of N-Linked Oligosaccharides Due to Glucosidase I DeficiencyThe American Journal of Human Genetics, 2000